Transrectal ultrasound features and biopsy outcomes of transition PI-RADS 5

被引:7
作者
Chung, Jae Hoon [1 ]
Park, Byung Kwan [2 ]
机构
[1] Sungkyunkwan Univ, Dept Urol, Samsung Med Ctr, Sch Med, Seoul, South Korea
[2] Sungkyunkwan Univ, Dept Radiol, Samsung Med Ctr, Sch Med, 81 Irwon Ro, Seoul 06351, South Korea
关键词
Prostate; biopsy; magnetic resonance imaging; interventional ultrasonography; PROSTATE-SPECIFIC ANTIGEN; GUIDED BIOPSY; VERSION; TRANSURETHRAL RESECTION; CANCER DETECTION; ZONE BIOPSIES; 2.5; NG/ML; PSA;
D O I
10.1177/02841851211018775
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background Transition Prostate Imaging and Reporting and Data System (PI-RADS) 5 is easily detected owing to typical magnetic resonance imaging features. However, it is unclear as to how transition PI-RADS 5 appears on transrectal ultrasound (TRUS). Purpose To assess TRUS features of transition PI-RADS 5 and outcomes of TRUS-guided target biopsy. Material and Methods Between March 2014 and November 2018, 186 male patients underwent TRUS-guided biopsy of PI-RADS 5. Of them, 82 and 104were transition and peripheral PI-RADS 5, respectively. Transition and peripheral PI-RADS 5 were compared according to echogenicity (hyperechoic or hypoechoic) and hypoechoic rim (present or absent). Each tumor was targeted with TRUS based on TRUS features. Significant (Gleason score >= 7) and insignificant (Gleason score 6) cancer detection rates (CDRs) were compared between transition and peripheral PI-RADS 5. Standard reference was biopsy examination. Fisher's exact test was used for statistical analysis. Results Transition PI-RADS 5 was hyperechoic in 89.0% (73/82) and had a hypoechoic rim in 97.6% (80/82), whereas peripheral PI-RADS 5 was hypoechoic in 99.0% (103/104) and had a hypoechoic rim in 26.9% (28/104) (both, P<0.0001). The significant CDRs of transition and peripheral PI-RADS 5 were 56.1% (46/82) and 65.4% (68/104), respectively (P=0.2263). However, the insignificant CDRs of these categories were 22.0% (18/82) and 8.7% (9/104), respectively (P=0.0123). Conclusion Transition PI-RADS 5 tends to have hyperechoic echogenicity and a hypoechoic rim. These findings help to target the transition PI-RADS 5 using TRUS. However, transition PI-RADS 5 is confirmed more frequently as insignificant cancer than peripheral PI-RADS 5.
引用
收藏
页码:559 / 565
页数:7
相关论文
共 40 条
[1]   Validation of new TRUS biopsy techniques for PI-RADS 4 or 5 [J].
An, Taein ;
Park, Byung Kwan .
PRECISION AND FUTURE MEDICINE, 2020, 4 (04) :141-148
[2]   Value of systematic biopsy added to target biopsy for detecting significant cancer in men with Prostate Imaging and Reporting and Data System 5 [J].
An, Taein ;
Park, Byung Kwan .
PRECISION AND FUTURE MEDICINE, 2020, 4 (03) :107-113
[3]   Multifocal prostate cancer: biologic, prognostic, and therapeutic implications [J].
Andreoiu, Matei ;
Cheng, Liang .
HUMAN PATHOLOGY, 2010, 41 (06) :781-793
[4]   The Value of an Extensive Transrectal Repeat Biopsy with Anterior Sampling in Men on Active Surveillance for Low-risk Prostate Cancer: A Comparison from the Randomised Study of Active Monitoring in Sweden (SAMS) [J].
Bratt, Ola ;
Holmberg, Erik ;
Andren, Ove ;
Carlsson, Stefan ;
Drevin, Linda ;
Johansson, Eva ;
Josefsson, Andreas ;
Nyberg, Maria ;
Sandberg, Jonas ;
Stattin, Par ;
Robinsson, David .
EUROPEAN UROLOGY, 2019, 76 (04) :461-466
[5]   The detection of significant prostate cancer is correlated with the Prostate Imaging Reporting and Data System (PI-RADS) in MRI/transrectal ultrasound fusion biopsy [J].
Cash, Hannes ;
Maxeiner, Andreas ;
Stephan, Carsten ;
Fischer, Thomas ;
Durmus, Tahir ;
Holzmann, Josephine ;
Asbach, Patrick ;
Haas, Matthias ;
Hinz, Stefan ;
Neymeyer, Joerg ;
Miller, Kurt ;
Guenzel, Karsten ;
Kempkensteffen, Carsten .
WORLD JOURNAL OF UROLOGY, 2016, 34 (04) :525-532
[6]  
Djavan B, 1999, Tech Urol, V5, P139
[7]   UNUSUAL HYPERECHOIC APPEARANCE OF PROSTATE-CANCER ON TRANSRECTAL ULTRASONOGRAPHY [J].
EGAWA, S ;
WHEELER, TM ;
GREENE, DR ;
SCARDINO, PT .
BRITISH JOURNAL OF UROLOGY, 1992, 69 (02) :169-174
[8]   Evidence suggesting PSA cutpoint of 2.5 ng/mL for prompting prostate biopsy: Review of 36,316 biopsies [J].
Gilbert, SM ;
Cavallo, CB ;
Kahane, H ;
Lowe, FC .
UROLOGY, 2005, 65 (03) :549-553
[9]   Validation of the Dominant Sequence Paradigm and Role of Dynamic Contrast-enhanced Imaging in PI-RADS Version 2 [J].
Greer, Matthew D. ;
Shih, Joanna H. ;
Lay, Nathan ;
Barrett, Tristan ;
Bittencourt, Leonardo Kayat ;
Borofsky, Samuel ;
Kabakus, Ismail M. ;
Law, Yan Mee ;
Marko, Jamie ;
Shebel, Haytham ;
Mertan, Francesca V. ;
Merino, Maria J. ;
Wood, Bradford J. ;
Pinto, Peter A. ;
Summers, Ronald M. ;
Choyke, Peter L. ;
Turkbey, Baris .
RADIOLOGY, 2017, 285 (03) :859-869
[10]   Validation of Prostate Imaging Reporting and Data System Version 2 for the Detection of Prostate Cancer [J].
Hofbauer, Sebastian L. ;
Maxeiner, Andreas ;
Kittner, Beatrice ;
Heckmann, Robin ;
Reimann, Maximillian ;
Wiemer, Laura ;
Asbach, Patrick ;
Haas, Matthias ;
Penzkofer, Tobias ;
Stephan, Carsten ;
Friedersdorff, Frank ;
Fuller, Florian ;
Miller, Kurt ;
Cash, Hannes .
JOURNAL OF UROLOGY, 2018, 200 (04) :767-772